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Abstract:
Comorbid states of diseases significantly complicate diagnosis and treatment. Molecular mechanisms of co-
morbid states of asthma and hypertension are still poorly understood. Prioritization is a way for identifying
genes involved in complex phenotypic traits. Existing methods of prioritization consider genetic, expression
and evolutionary data, molecular-genetic networks and other. In the case of molecular-genetic networks, as a
rule, protein-protein interactions and KEGG networks are used. ANDSystem allows reconstructing associative
gene networks,which includemore than 20 types of interactions, including protein-protein interactions, expres-
sion regulation, transport, catalysis, etc. In this work, a set of genes has been prioritized to find genes potentially
involved in asthma and hypertension comorbidity. The prioritization was carried out using well-known meth-
ods (ToppGene and Endeavor) and a cross-talk centrality criterion, calculated by analysis of associative gene
networks from ANDSystem. The identified genes, including IL1A, CD40LG, STAT3, IL15, FAS, APP, TLR2, C3,
IL13 and CXCL10, may be involved in the molecular mechanisms of comorbid asthma/hypertension. An anal-
ysis of the dynamics of the frequency of mentioning the most priority genes in scientific publications revealed
that the top 100 priority genes are significantly enriched with genes with increased positive dynamics, which
may be a positive sign for further studies of these genes.
Keywords: ANDSystem, associative gene network, asthma, comorbid disease, dynamics of interest of genes in
publications, gene prioritization, hypertension
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1 Introduction
Asthma is a chronic inflammatory disease of the respiratory tract, the main characteristics of which are the
hypersensitivity of the airways to various stimuli and reversible airflow obstruction [1]. More than 300 million
patients worldwide are suffering from this disease [2]. Another widespread disease in the world is hyperten-
sion, which is characterized by a persistent increase in blood pressure from 140/90 mmHg. Art. and higher [3].
Annually about nine million people die due to complications associated with hypertension [4]. A number of
studies have shown that asthma is related to an increase in the incidence of cardiovascular diseases [5], [6]. In
this regard, the combination of asthma and arterial hypertension (comorbidity) in a large percentage of clinical
cases is not surprising. Prevalence of hypertension in asthma patients is high with odds ratio = 1.66 [147], [188],
p-value  <  0.00001 [7]. This may not be a simple coincidence, because standard asthma mechanisms have been
implicated in key processes of initiation of hypertension. Good examples of this are the establishment of the role
of arachidonic acid-leukotriene B4 production in spontaneously hypertensive rat [8] or the value of Th17 and
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IL17 in arterial hypertension [9]. Therapeutic control of allergic inflammation leads to better control of blood
pressure [10]. The important role of the transcription factor STAT3, which is involved in signal transduction
for a variety of cytokines and takes an active part in allergic inflammation [11], [12] and vascular remodeling
[13], is well-known. On the basis on this information, it can be assumed that the imbalance between the pro-
inflammatory and anti-inflammatory factors in the body creates the optimal situation for the realization of a
hereditary predisposition to both asthma and arterial hypertension. In addition to the important role played by
immune responses and control of inflammation in the pathogenesis of asthma and hypertension, it is also possi-
ble to assume the involvement of other mechanisms underlying the comorbidity of these diseases. For example,
β-adrenoblockers and ACE inhibitors, which for a long time were contraindicated for patients with bronchial
asthma due to possible bronchospasm, are widely used in the treatment of hypertension. Polymorphism of β-
adrenoreceptor genes is associated with the risk of hypertension and bronchial asthma [14], [15]. It is assumed
that mutations in the SLC26A4 gene can play an important role in the pathogenesis of bronchial asthma and hy-
pertension, and therefore in the comorbidity of these diseases [16], [17], [18]. However, despite the accumulated
data on the participation of specific genes simultaneously in asthma and hypertension, the mechanisms of in-
teraction of these two diseases and the formation of their comorbid state are still poorly understood. Previously,
we performed the prioritization of genes that are associated with asthma and hypertension simultaneously, to
find the candidates which can potentially be involved in the mechanisms of comorbidity of these two diseases
[19].
In the present work, a prioritization of an extended set of genes, which are associated either with asthma or
with hypertension, was carried out. In addition, a new criterion for prioritization, based on the assessment of
cross-talk centrality, previously used by us for the prioritization of neuronal apoptosis genes in the associative
gene network of Parkinson’s disease [20], was introduced. When assessing the quality of prioritization, this cri-
terion was of the best significance. Among the most significant genes were cytokines (CXCL10, CD40LG, IL1A,
IL13 and IL15), toll-like receptor TLR2, death domain receptor FAS, transcription factor STAT3, complement
factor C3 and amyloid beta precursor protein APP. An analysis of the overrepresentation of Gene Ontology
biological processes for the top 100 highest-priority genes has shown the potential importance of the response
to hypoxia, the inflammatory and immune responses and regulation of the apoptotic process in the mechanism
of interaction of asthma and hypertension. In addition, we analyzed the dynamics of interest in genes by the
frequency of their mention in scientific publications. It appeared that genes simultaneously associated with
asthma and hypertension are enriched with genes that have a high positive dynamic of interest in them from
researchers. This fact may indicate the involvement of these genes in many mechanisms of manifestation of
various phenotypic traits that can determine the importance of their role in the development of comorbidity
of diseases. An analysis of the most priority genes also showed significant enrichment with genes that have a
high dynamic of interest in them. This may indicate their involvement in multiple phenotypic signs and, ac-
cordingly, in the comorbidity of asthma and hypertension. The genes identified as a result of prioritization can
be used in the planning of experiments on genotyping and search for associations with the comorbid state of
asthma and hypertension.
2 Methods
The sets of genes associated with asthma and hypertension were extracted from the ANDSystem knowledge
base [21], [22]. The set of genes associated with asthma included 749 genes. The set of genes associated with
hypertension included 706 genes. The number of genes simultaneously presented in the first and second sets
was 202. A test set of genes, used for prioritization, was obtained by combining sets of asthma and hypertension
genes, minus the 202 genes gained by the intersection of these two sets. The total number of genes in the test
set was 1051.
The over-represented Gene Ontology biological processes were identified using the DAVID 6.8
service [23] with the following parameters: the organism – ”Homo sapiens”, Gene_Ontology –
”GOTERM_BP_DIRECT”.
The reconstruction of associative gene networks was carried out with ANDSystem tool [21], [22].
To prioritize the genes we used four criteria, which we previously discussed in the analysis of asthma,
hypertension and Parkinson’s disease [19], [20]. Criteria 1 and 2 were based on the well-known methods of
prioritization: ToppGene [24] (https://toppgene.cchmc.org/prioritization.jsp) and Endeavor [25] version 3.71
(https://endeavour.esat.kuleuven.be/), respectively. The ToppGene and Endeavor programs allow one to per-
form a ranking of a test set of genes by a training set of genes, according to specific criteria characterizing
the proximity of genes from the test set to the genes from the training sample. The genetic information (co-
localization in the genome), the functional properties of genes (participation in the same GO categories), etc.,
2
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can be used by these programs as properties of the vertices of the graph of protein-protein networks. As a train-
ing set for each of these programs, a list of genes associated with asthma and hypertension, described above,
was provided, while a list of 1051 genes, which is also described above, was used as a test set.
For the ToppGene in the Training parameters section, all features were selected. The ”Rank” indicator of
the ToppGene program was used to rank the genes. In the case of the Endeavor system, all settings were set by
default. The ranking of genes was carried out according to the ”p-value” indicator of the Endeavor program.
The lowest rank received geneswith the lowest values of ”p-value”, and the largest rank – geneswith the highest
values of ”p-value”.
Criterion 3 reflects the specificity of association of biological processes in which the analyzed gene partici-
pates with comorbidity mechanisms. Criterion 3 was calculated by formula N1/N2, where N1 is a number of
the Gene Ontology biological processes, overrepresented for a set of genes associated with asthma and hyper-
tension; N2 is a number of all Gene Ontology biological processes in which the analyzed gene was involved.
Information indicating that the gene is involved in the Gene Ontology biological process was obtained from the
AmiGO system [26]. Ranks for genes were determined by sorting the list of genes by descending the number
of over-represented Gene Ontology biological processes. Thus, the lowest rank was attributed to the gene for
which the number of the over-represented Gene Ontology biological processes was the highest.
To calculate criterion 4, an associative gene network which describes the interactions between the analyzed
gene/protein and the genes/proteins from the training set was used. The network was automatically recon-
structed by ANDSystem. Criterion 4 was based on the use of the cross-talk centrality (CTC), calculated using
the “Intelligent Filtration” function of the “ANDVisio” program. Within this criterion, the CTC value was cal-
culated separately for vertices in the gene network corresponding to the gene and its product (protein). Thus,
for the gene, two indices (CTCgene and CTCprotein) were determined.
The CTCgene was calculated by the formula:
CTCgenei = 𝑁𝑖/𝑀, (1)
where Ni – is a number of links of the i-th gene with members of the associative gene network of asthma/hy-
pertension;M – is a number of vertices of the associative gene network of asthma/hypertension. CTCprotein for
the i-th protein was determined the same way. The CTCgene and CTCprotein grades were determined by sorting
the values in descending order, like in the case of criterion 3.
In the case when several genes had the same value for the criterion under which the rankingwas conducted,
the rank of these genes was calculated the similar way as the Spearman rank correlation coefficient [27]. Such
genes were assigned the same rank, equal to the average arithmetic ranks of these genes, according to their
position, in the sorted list of genes.
As the fifth criterion, the average value of the ranks obtained according to the criteria 1–4 was taken like it
was done in [19].
For the reconstruction of the dynamics, the information on investigated genes from PubMed publications
for the period from 1990 to 2017 were considered. For each year from this period, the number of publications in
which the analyzed genewasmentionedwas calculated. Themarking of gene names in the texts of publications
was carried out by using the ANDSystem. The trend reflecting the dynamics of the number of gene references
in the articles was calculated using the Pearson correlation coefficient between the year and the total number of
articles published this year in which the gene was mentioned. The enrichment of the gene set with genes with
increased interest dynamics was calculated using the hypergeometric distribution realized in the hypergeom.sf
function of the scipy.stats package of the Python programming language [28]. Genes with high dynamics of
interest were genes for which the Pearson correlation coefficient exceeded 0.9.
3 Results andDiscussion
To prioritize the genes for their potential simultaneous involvement in asthma and hypertension 749 genes of
asthma and 706 genes of hypertension were considered. The training set of genes consisted of 202 genes, which
were presented both in asthma and hypertension lists. Prioritization was carried out by using 4 criteria (see
Online Appendix 1). The ranking of genes was carried out according to the value calculated as the mean for the
ranks of the genes obtained using each of the 4 criteria. The top 10 of themost significant genes is listed in Table
1. Among themwere cytokines (CXCL10, CD40LG, IL1A, IL13 and IL15), toll-like receptor TLR2, death domain
receptor FAS, transcription factor STAT3, complement component C3 and amyloid beta precursor protein APP.
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It is interesting to note that all these genes are genes from the group of asthma. At the same time, the ratio of
asthma genes to the genes of hypertension in the top 100 of the most significant genes appeared to be 2:1.
Table 1: Top 10 of the most significant genes.
Gene
symbol
GeneID Criterion 1 Criterion 2 Criterion 3 Criterion 4
A
Criterion 4 B Average of
criteria 1–4
ToppGene Endeavour GO BP Gene CTC Protein CTC
IL1A 3552 17 102 80.00 2 11 42.4
CD40LG 959 3 72 113.50 23 4 43.1
STAT3 6774 50 4 143.00 18 2 43.4
IL15 3600 72 129 38.00 13.5 36.5 57.8
FAS 355 35 18 52.00 177.5 20 60.5
APP 351 25 16 263.00 5 19 65.6
TLR2 7097 6 75 84.00 146 22 66.6
C3 718 49 67 84.00 49.5 88.5 67.6
IL13 3596 5 110 33.50 177.5 14.5 68.1
CXCL10 3627 7 92 86.00 55 101.5 68.3
Figure 1 shows that the top 10 genes are relatively well connected to each other inside the associative gene
network, reconstructed with ANDSystem (see Online Appendix 2). In particular, the transcription factor STAT3
regulates CXCL10 [29] and Fas [30]. In turn, TLR2, IL-13 and IL-15 regulate the activity of STAT3 [31], [32], [33].
Figure 1: An associative gene network reconstructed with ANDSystem, illustrating the interactions of the top 10 of most
significant genes.
For better understanding which biological processes can underlie the molecular mechanisms of interaction
between asthma and hypertension, an analysis of the overrepresentation of Gene Ontology biological processes
on two sets of data was conducted: the training set of genes and the top 100 of the highest priority genes from
the table in Online Appendix 1 were analyzed. For the set of genes associated with asthma and hypertension
simultaneously, there were found 69 significantly over-represented biological processes (p-value < 0.05 with
FDR correction). For the top 100 of the most priority genes, there were 42 such processes. Twenty-two biolog-
ical processes were over-represented simultaneously for these two sets of genes (see Online Appendix 3). For
example, the response to hypoxia had the best relevance for the training set of genes (p-value < 10−12). In the
second set of genes, the p-value for this process was <10−8, and the most significant process appeared to be
the inflammatory response (p-value < 10−19). The intersection of over-represented processes was more than
50% of the total number of all overrepresented processes for a set of top 100 priority genes. Such a high value
was partly related to the 3rd criterion of prioritization, which was based on considering the overrepresented
biological processes. But since the ranking was performed by using the rank averaged over all 4 criteria, such
intersection indirectly confirms the correctness of the prioritization.
It should be noted that the manual analysis of the full-text articles of PubMed Central showed that for genes
from the top 10 there was additional information that was not represented in ANDSystem that speaks in favor
of their possible connection with hypertension. For example, for the IL1A gene, it is known that in Chinese
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Han population genetic variations in IL1A are associated with the risk of preeclampsia, which is characterized
by hypertension and proteinuria [34]. In addition in Chinese children with type 1 diabetes the prevalence of
hypertension in carriers of T allele in the IL1A gene was 4.2-fold higher than for C allele carriers with p-value <
0.001 [35]. The article [36] stated that the down-regulation of CD40LG might be related to kidney dysfunction
in an early phase of hypertension, and [37] discussed that CD40LG was included in pulmonary hypertension
gene subnetwork. Gene STAT3 regulate angiogenesis and vasoconstriction and is involved in the development
of portal hypertension [38]. In patients with essential hypertension, IL-15might be involved in the development
of cardiovascular diseases [39]. For gene FAS it was shown that its expression was significantly increased in
spontaneously hypertensive rats compared to Wistar-Kyoto rats [40]. In [41] APP was identified to undergo
differential ubiquitination during pulmonary hypertension pathogenesis. Hypomethylation of the TLR2 gene
increased the risk of essential hypertension in the Chinese population [42]. It was shown that C3 is highly
expressed inmesenchymal tissues in spontaneously hypertensive rats (SHR) [43] and increased C3 induces salt-
sensitive hypertension in SHR [44]. In [45] was discussed that IL-13 was involved in the induction of pulmonary
hypertension. CXCL10 appeared to be involved in the pathogenesis of hypertension [46] and its level in serum
was elevated in untreated essential hypertension [47].
One of the interesting characteristics of a gene may be the dynamics of increasing researcher’s interest in
this gene, which may reflect the prospect of its study. It turned out that the genes from the training set, si-
multaneously associated with asthma and hypertension, are statistically significantly enriched with genes that
have a high positive dynamic of their mention in the scientific publications of PubMed (p-value < 10−15). The
total number of genes with a positive growing trend (r > 0.9) was 872 of the 17,868 human genes, presented in
the ANDSystem. Among the 202 genes of the training set, it appeared to be 20% of such genes (42 genes). The
HMOX1 gene, which encodes heme oxygenase 1, possessed the greatest positive dynamics of interest (r = 0.99).
It is interesting to note that the top 100 of most priority genes contained 25% of genes possessing increased
positive dynamics of interest. This enrichment was also statistically significant (p-value < 10−11). Analysis of
the top 5 genes showed that among them STAT3 belongs to the group of 25% of genes possessing increased
positive dynamics of interest (r = 0.96). The differences in the dynamics of interest for genes from the top 5
group are shown in Figure 2.
Figure 2: The dynamics of researcher’s interest for the top 5 most priority genes, according to scientific publications of
PubMed.
Gene STAT3 encodes a protein that in response to cytokines and growth factors is phosphorylated and
translocated to the nucleus where it starts to act as a transcription activator [48]. STAT3 is involved in many
cellular processes including cell growth and apoptosis [49].
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4 ConcludingRemarks
It is well known that many diseases are comorbid, which significantly complicates their treatment, and also
prevents their proper diagnosis. The study of the molecular mechanisms of comorbid states is an urgent task
of the modern biomedicine. Asthma and hypertension are examples of widespread comorbid diseases. In this
study, we used prioritizationmethods, including existingwell-knownmethods (ToppGene and Endeavor), and
an approach (cross-talk centrality), based on the analysis of associative gene networks from ANDSystem, to
find genes that could potentially be involved in asthma and hypertension simultaneously. Cytokines (CXCL10,
CD40LG, IL1A, IL13 and IL15), toll-like receptor TLR2, death domain receptor FAS, transcription factor STAT3,
complement factor C3 and amyloid beta precursor protein (APP), appeared to be the most significant. In ad-
dition, an analysis of the dynamics of the frequency of mentioning genes in scientific publications was carried
out. It turned out that the top 100 of the priority genes are significantly enriched by genes with increased pos-
itive dynamics of researcher’s interest in them. This may indicate a promise for further researches on these
genes. A further study of the predicted genes, simultaneously involved in asthma and hypertension, can help
to illuminate the mechanisms of the comorbid state of these two diseases.
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